Aviva's H1 profit climbs 24% and the Direct Line effect shows in personal lines

Aviva opened its 2026 reporting season with a first-half operating profit of £1,326 million, a 24% increase on the prior year and the strongest interim result under the group's current structure. Operating earnings per share rose 10% to 31.8p, IFRS return on equity reached 20.3%, and cash remittances climbed 47% to £1,498 million. The board raised the interim dividend by 7% to 14.0p per share.

The headline personal lines swing was almost entirely mechanical: UK personal lines premiums rose 98% to £3,679 million because Direct Line's acquisition completed in July 2025 and was absent from the year-earlier comparator. The better measure is underwriting performance: the personal lines combined ratio improved by 0.8 percentage points to 93.1%. Aviva says Direct Line motor policies sold through price comparison websites grew 7%, with customer satisfaction measures above 50.

Commercial lines moved in the opposite direction. UK commercial premiums fell 4% to £1,927 million, while the combined ratio ticked up 0.2 percentage points to 93.7%. Group CEO Amanda Blanc framed the group's long-term growth areas as Wealth, UK and Canada General Insurance, Global Corporate and Specialty, and Health and Protection. The capital position remained strong, with a Solvency II shareholder cover ratio of 176%, expected to recover toward the high 180s by year-end as remaining Direct Line capital synergies clear regulatory approval.

Where Aviva is building, holding the line and reducing exposure

UK commercial: deliberately shrinking to protect margin

Aviva is telling the market it will accept less volume rather than write business at inadequate rates. The 4% fall in UK commercial premiums to £1,927 million is not a distribution failure; management describes it as deliberate underwriting discipline in softer market conditions. The combined ratio of 93.7% supports that reading: a modest 0.2 percentage-point deterioration while volume falls points to selective underwriting rather than a scramble for share. Aviva has also said it expects the softer rating environment to continue through the rest of 2026.

Advertisement

For brokers, the practical implication is that competitive premium alone will not be enough. The carrier has signaled that submissions need to demonstrate underwriting quality, with margin prioritised over top-line growth.

The exception: Global Corporate and Specialty

Aviva is not applying the same defensive posture everywhere. Global Corporate and Specialty was explicitly named as a long-term growth platform. Strong April renewals in GCS partly offset weaker conditions in the broader commercial book, and the unit operates through both Aviva's company market and Lloyd's platforms. That makes it the corner of the book where brokers with large corporate, specialty or multinational risks should expect Aviva to compete to build, not to manage for stability.

Direct Line integration is ahead of schedule

The personal lines comparison requires context. The 98% premium increase is mainly an acquisition effect, but the underwriting trend is positive: the combined ratio improved to 93.1%. The integration indicators are moving quickly. All Direct Line employees have transferred to Aviva, nearly £5 billion of assets have moved to Aviva Investors, and £100 million of run-rate cost synergies have been delivered toward the £225 million target. Customer metrics cited by Aviva include a TNPS above 50 and improved motor claims satisfaction, which reduces transition risk for clients already on the Direct Line book.

Wealth is growing, while health is resetting

Wealth was the fastest-growing segment Aviva highlighted, with operating profit up 34% to £102 million. The workplace business won 232 new schemes in the half, net flows grew 36% to £5.1 billion, and the initial transfers from the Mercer Master Trust added £1.5 billion. The adviser platform expanded to 460,000 customers, 10% higher than a year earlier. In health, the picture is different: in-force premiums grew 5% on pricing ahead of inflation, but new business sales fell 33% to £51 million as Aviva defended rate discipline in consumer and SME channels. The group lowered its full-year health operating profit guidance to roughly £90 million.

Advertisement

AI moves into claims and underwriting

Aviva said it is accelerating AI deployment across claims, underwriting and Wealth. The operationally significant item for brokers is an AI-enabled claims agent, because a first-response claims tool directly affects settlement speed and the post-loss experience of clients. Other changes include faster medical underwriting review times, automated quality assurance in Wealth, and a virtual assistant planned for later this year.

Broker implications: commercial renewals, workplace pitches and SME health placement

For UK brokers and advisers, the result is less a set of headline numbers and more a guide to where Aviva will compete and where it will defend terms.

  • Commercial renewals: With premiums down 4% and the combined ratio at 93.7%, expect Aviva to hold underwriting standards for the remainder of 2026. Submissions should lead with underwriting quality, because Aviva has said it is prioritising profitable growth over volume.
  • Large and specialty risks: Direct new business effort toward Global Corporate and Specialty. Aviva named it a long-term growth platform and said strong April renewals in GCS partially offset the softer broader market.
  • Workplace and adviser distribution: Aviva is investing in client acquisition at scale. It won 232 new workplace schemes and grew net flows 36% to £5.1 billion in six months; brokers and advisers should use that pipeline to press for a detailed servicing proposition rather than accepting price as the only lever.
  • SME health: Aviva's health new business sales fell 33% to £51 million and full-year health operating profit guidance was lowered to about £90 million. Brokers placing SME health should expect Aviva to hold rate rather than chase price; the growth focus is on the large corporate segment.
  • Direct Line intermediated clients: The integration has transferred all Direct Line employees, moved nearly £5 billion of assets, and maintained customer service measures with a TNPS above 50. Use that continuity to reassure clients mid-policy.

Risk & Opportunity Assessment

Commercial RiskMediumAviva has explicitly forecast softer rating conditions for the rest of 2026 and is accepting lower UK commercial premium volume to protect margin; if softness deepens, commercial income may stay under pressure.
Competitive RiskMediumIn UK commercial and SME health, Aviva is holding pricing discipline while competitors chase volume; it may lose market share in the short term even as it protects profitability.
Regulatory RiskLowSolvency II cover of 176% is comfortably within range, but more than £350 million of Direct Line capital synergies still require regulatory approval.
Reputation RiskLowDirect Line customer service metrics remain above 50 TNPS and motor claims satisfaction improved, reducing integration-related reputation risk.
Technology DisruptionMediumAviva is deploying AI across claims, underwriting and wealth, including an AI-enabled claims agent; this could change speed and cost but carries execution risk.
Commercial OpportunityHighWealth, UK and Canada General Insurance, Global Corporate and Specialty, and Health and Protection are named growth areas; Wealth operating profit rose 34% and workplace net flows rose 36%.